Home Newsfeeds Baird Maintains Outperform on Frequency Therapeutics, Lowers Price Target to $4

Baird Maintains Outperform on Frequency Therapeutics, Lowers Price Target to $4

Baird analyst Jack Allen maintains Frequency Therapeutics (NASDAQ:FREQ) with a Outperform and lowers the price target from $10 to $4.

byBenzinga Newsdesk

February 14, 2023

1 minute read

Baird analyst Jack Allen maintains Frequency Therapeutics (NASDAQ:FREQ) with a Outperform and lowers the price target from $10 to $4.

News

Why Occidental Petroleum (OXY) Stock Is Rising

By Henry Khederian

October 9, 2:53 PM

Occidental Petroleum Corp (NYSE: OXY) shares are trading higher by 4.35% to $64.07 Monday afternoon. Energy stocks have surged Monday amid growing oil supply concerns resulting from the Israel-Hamas conflict.

OXY

General
News

GM CEO Mary Barra Says 2023 Challenges Were Just ‘Bumps In The Road,’ Automaker Confident In All Aspects Of Future Business

By Adam Eckert

November 29, 12:34 PM

General Motors Co (NASDAQ: GM) is in the spotlight Wednesday after the company reinstated guidance and announced an accelerated buyback.

Zoom Video Silently Makes Its Debut On Apple TV 4K: Here’s How You Can Use It

By Benzinga Neuro

December 3, 9:15 PM

Zoom Video has made its debut on Apple TV 4K, leveraging iPhone cameras through a stand and the Continuity Camera feature to offer a new platform for hosting and joining meetings, with features like calendar integration, potentially enhancing its market performance post robust Q3 financial results.

AAPL